Ad
NWBO - Northwest Biotherapeutics Stock Trading
About | Northwest Biotherapeutics Inc. (OTCMKTS:NWBO)
None
Quote | Northwest Biotherapeutics Inc. (OTCMKTS:NWBO)
| Last: | $1.04 |
|---|---|
| Change Percent: | 1.0% |
| Open: | $0.99 |
| Close: | $1.04 |
| High: | $1.09 |
| Low: | $0.9501 |
| Volume: | 3,837,568 |
| Last Trade Date Time: | 09/25/2023 03:00:00 am |
News | Northwest Biotherapeutics Inc. (OTCMKTS:NWBO)
-
LAS VEGAS, NV / ACCESSWIRE / September 25, 2023 / Crown Equity Holdings, Inc. (OTC PINK:CRWE) today announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") for a proposed public offering of its common stock. The public offering is ...
-
Northwest Biotherapeutics Announces That Dr. Linda Liau Has Joined The Company's Scientific Advisory Board PR Newswire BETHESDA, Md. , Sept. 12, 2023 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax &#...
Message Board Posts | Northwest Biotherapeutics Inc. (OTCMKTS:NWBO)
| Subject | By | Source | When |
|---|---|---|---|
| https://brownneurosurgery.com/breakthrough-brain-cancer-vaccine/ | hope4patients | investorshub | 09/25/2023 10:56:42 PM |
| Absolutely | hope4patients | investorshub | 09/25/2023 10:55:56 PM |
| Same. | StonkMaster | investorshub | 09/25/2023 10:48:16 PM |
| Everyone of the shorts on here know site | extrooper | investorshub | 09/25/2023 10:46:56 PM |
| The SEC keeps that FTD data updated every | sentiment_stocks | investorshub | 09/25/2023 10:45:46 PM |
Northwest Biotherapeutics Inc. Company Name:
NWBO Stock Symbol:
OTCMKTS Market:
Northwest Biotherapeutics Inc. Website:
Ad
-
LAS VEGAS, NV / ACCESSWIRE / September 25, 2023 / Crown Equity Holdings, Inc. (OTC PINK:CRWE) today announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") for a proposed public offering of its common stock. The public offering is ...
-
Northwest Biotherapeutics Announces That Dr. Linda Liau Has Joined The Company's Scientific Advisory Board PR Newswire BETHESDA, Md. , Sept. 12, 2023 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax &#...
-
Northwest Biotherapeutics Announces Completion of Prerequisites, and Plans for Submission of Marketing Authorization Application PR Newswire BETHESDA, Md. , Aug. 29, 2023 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company ...